✦ LIBER ✦

Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 oral suspension (liquid formulation) in Finnish infants

✍ Scribed by T. Vesikari; A. Karvonen; A. Bouckenooghe; P.V. Suryakiran; I. Smolenov; H.H. Han

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity, Reactogenicity and Safet

✍ D.D. Anh; V.D. Thiem; Y. Hutagalung; H.L. Bock; P. Suryakiran; A. Delem; H.H. Ha 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Immunogenicity of The Oral Live Attenuat

✍ A.A. Velasquez; E. Dominguez; P.V. Suryakiran; A. Delem; E. Ortega-Barria; H.H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Co-Administration of a Human Rotavirus V

✍ V.K. Tatochenko; V.V. Romanenko; S.M. Kharit; I. Smolenov; I. LeFevre; N. De Cle 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Immunogenicity, reactogenicity and safet

✍ D.D. Anh; C.C. Carlos; D.V. Thiem; Y. Hutagalung; S. Gatchalian; H.L. Bock; I. S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Safety and immunogenicity of RIX4414 liv

✍ T Vesikari; A Karvonen; T Korhonen; M Espo; E Lebacq; J Forster; F Zepp; A Delem 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Co-administration study in South African

✍ A.D. Steele; B. De Vos; J. Tumbo; J. Reynders; F. Scholtz; P. Bos; M.C. de Beer; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 262 KB